Cash flow generation appears mixed, with FFO consistently exceeding operating cash flow, but the dividend payout ratio relative to FFO has risen to 81.3% and the complete absence of reported AFFO data obscures the true sustainability of distributions.
Universal Health Realty Income Trust (UHT) cash flow statement — 30-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Cash from Operations | 48.25M | 49.09M | 46.91M | 43.47M | 46.8M | 47.73M | 44.21M | 42.65M | 42.93M | 46.01M | 40.73M | 38.18M | 32.8M | 31.29M | 30.78M | 21.37M | 23.05M | 24.98M | 21.84M | 22.77M | 24.7M | 25.3M | 26.99M | 29.08M | 26.29M | 22.78M | 19.97M | 19.58M | 18.66M | 17.71M | 18M |
| Operating CF Growth % | 0.77% | 4.65% | 7.91% | -7.12% | -1.93% | 7.95% | 3.65% | -0.64% | -6.69% | 12.94% | 6.69% | 16.41% | 4.8% | 1.66% | 44.03% | -7.28% | -7.75% | 14.39% | -4.1% | -7.8% | -2.38% | -6.24% | -7.19% | 10.62% | 15.4% | 14.06% | 2% | 4.95% | 5.36% | -1.65% | 5.45% |
| Operating CF / Revenue % | 32.43% | 49.49% | 47.38% | 45.49% | 51.65% | 56.69% | 56.67% | 55.28% | 56.33% | 63.59% | 60.72% | 59.7% | 54.86% | 57.65% | 57.06% | 72.46% | 79.82% | 78.29% | 74.84% | 81.46% | 77.89% | 77.64% | 87.02% | 110.53% | 96.75% | 86.57% | 76.65% | 82.04% | 80.29% | 76.65% | 82.12% |
| Net Income | 19.27M | 17.61M | 19.23M | 15.4M | 21.1M | 109.17M | 19.45M | 18.96M | 24.2M | 45.62M | 17.21M | 23.69M | 51.55M | 13.17M | 19.48M | 73.79M | 16.31M | 18.58M | 11.65M | 22.19M | 34.7M | 25.42M | 23.67M | 24.43M | 21.62M | 18.35M | 16.26M | 13.97M | 14.3M | 14M | 14.2M |
| Depreciation & Amortization | 28.83M | 28.69M | 28.01M | 27.73M | 27.13M | 27.3M | 25.39M | 25.67M | 24.76M | 25.09M | 23.01M | 22.2M | 20.98M | 18.84M | 20.22M | 7.31M | 6.29M | 6.4M | 5.9M | 5.21M | 5.76M | 5.83M | 5.31M | 4.54M | 4.43M | 4.4M | 4.46M | 3.86M | 3.88M | 3.77M | 3.64M |
| Stock-Based Compensation | 903K | 936K | 853K | 780K | 780K | 947K | 912K | 702K | 571K | 538K | 481K | 427K | 399K | 375K | 329K | 281K | 343K | 286K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.42M | -1.13M | -503K | 2.09M | -50K | -87.95M | -258K | -1.14M | -5.97M | -2.94M | -852K | -8.97M | -25.72M | -433K | -657K | -65.18M | 0 | 286K | 4.58M | -4.28M | -15.82M | -5.48M | -2.04M | -202K | 164K | -17K | -756K | 1.2M | 161K | 318K | 303K |
| Working Capital Changes | 673K | 2.98M | -1.19M | -1.75M | -2.15M | -1.73M | -1.29M | 404K | -634K | 4.89M | 881K | 829K | -1.36M | -660K | -62K | -186K | 110K | -277K | -290K | -343K | 66K | -463K | 39K | 318K | 68K | 45K | 9K | 550K | 315K | -387K | -136K |
| Cash from Investing | -16.84M | -14.96M | -13.88M | -19.87M | -36.67M | -24.43M | -27.21M | -16.47M | -7.96M | 39.46M | -74.83M | -44.31M | -4.04M | -13.51M | -8.56M | -3.28M | -17.3M | -12.36M | -26.92M | -4.34M | -2.04M | 8.41M | 11.88M | -13.05M | -1.43M | -8.33M | -8.91M | -14.44M | -27.21M | -541K | -19.46M |
| Acquisitions (Net) | -191K | -6.8M | -5.89M | -7.62M | -94K | -19.84M | -3.2M | -2.13M | -820K | -8.42M | -5.45M | -2.92M | -6.08M | -3.01M | -2.97M | -39.58M | 0 | -9.56M | -10.1M | 7.28M | -5.33M | -8.28M | -2.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | -19.64M | -22.58M | 0 | 0 | -14.45M | -820K | -532K | -5.45M | -667K | -1.34M | -3.01M | -2.97M | -3.79M | -15.58M | -6.9M | -13.82M | -24.92M | -7.57M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 0 | 0 | 0 | 7.39M | 22.58M | 0 | 0 | 2.77M | -6.61M | 51.63M | -4.39M | -3.47M | 20.52M | 114K | 14.43M | 39.58M | 0 | 4.1M | 0 | 10M | 1.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -16.65M | -8.15M | -7.98M | -7.43M | -22.96M | 8.41M | -21.74M | 2.45M | 4.34M | 5.83M | 851K | -20.49M | -1.53M | -2.93M | 551K | 40.86M | -755K | -12.36M | 1.71M | 10.54M | 10.21M | 19.08M | 15.2M | -12.74M | -1.38M | -7.78M | 895K | 3.42M | -27.06M | 3.71M | -9.26M |
| Cash from Financing | -31.14M | -34.55M | -34.15M | -23.01M | -25.02M | -6.54M | -17.37M | -25.11M | -33.32M | -86.01M | 34.14M | 6.16M | -29.82M | -17.49M | -30.82M | -7.43M | -7.8M | -10.2M | 4.57M | -18.11M | -23.22M | -35.58M | -36.39M | -15.99M | -24.89M | -14.11M | -11.62M | -4.86M | 7.89M | -16.06M | 1.45M |
| Dividends Paid | -41.37M | -41.03M | -40.39M | -39.77M | -39.18M | -38.53M | -37.97M | -37.41M | -36.83M | -36.05M | -35.14M | -34.09M | -32.72M | -31.75M | -31.2M | -30.7M | -29.86M | -28.41M | -27.74M | -27.2M | -26.63M | -25.59M | -23.49M | -22.96M | -22.44M | -20.58M | -16.53M | -16.21M | -15.72M | -15.26M | -15.17M |
| Common Dividends | -41.37M | -41.03M | -40.39M | -39.77M | -39.18M | -38.53M | -37.97M | -37.41M | -36.83M | -36.05M | -35.14M | -34.09M | -32.72M | -31.75M | -31.2M | -30.7M | -29.86M | -28.41M | -27.74M | -27.2M | -26.63M | -25.59M | -23.49M | -22.96M | -22.44M | -20.58M | -16.53M | -16.21M | -15.72M | -15.26M | -15.17M |
| Debt Issuance (Net) | 2M | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 132K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K | -1000K | -1000K | 1000K | 1000K | 1000K | -800K | 1000K |
| Share Repurchases | 0 | 0 | -131K | 0 | 0 | 0 | -267K | -221K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -236K | 0 | 0 | 0 | 0 | 0 | 0 | -181K | 0 | 0 | 0 | 0 |
| Other Financing | -35K | -35K | -2.38M | 0 | -26K | -1.84M | -467K | 177K | -1.67M | -446K | -337K | -1.19M | -94K | 5.56M | -106K | -1.23M | -532K | -298K | 9.77M | -527K | -108K | 0 | -435K | 0 | 0 | 0 | 0 | 0 | 10K | 0 | 25K |
| Net Change in Cash | 265K | -411K | -1.11M | 598K | -14.89M | 16.76M | -368K | 1.07M | 1.65M | -543K | 36K | 33K | 524K | 289K | -8.6M | 10.66M | -2.05M | 2.42M | -513K | 333K | -919K | -1.87M | 2.96M | 30K | -31K | 335K | -558K | 280K | -666K | 1.1M | -2K |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -359K | 0 | 475K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 7.06M | 7.1M | 8.21M | 7.61M | 22.5M | 5.74M | 6.11M | 5.04M | 3.39M | 3.93M | 3.89M | 3.86M | 3.34M | 3.05M | 11.65M | 987K | 3.04M | 618K | 1.13M | 798K | 1.72M | 3.59M | 628K | 598K | 629K | 294K | 852K | 572K | 1.24M | 137K | 139K |
| Cash at End | 6.82M | 6.69M | 7.1M | 8.21M | 7.61M | 22.5M | 5.74M | 6.11M | 5.04M | 3.39M | 3.93M | 3.89M | 3.86M | 3.34M | 3.05M | 11.65M | 987K | 3.04M | 618K | 1.13M | 798K | 1.72M | 3.59M | 628K | 598K | 629K | 294K | 852K | 572K | 1.24M | 137K |
| Free Cash Flow | 48.25M | 49.09M | 46.91M | 43.47M | 33.19M | 34.74M | 41.94M | 37.55M | 38.88M | 36.97M | -19.66M | 21.41M | 17.2M | 26.62M | 13.18M | -18.98M | 22.08M | 37.35M | 17.13M | 15.54M | 23.41M | 22.91M | 26.44M | 28.77M | 26.24M | 22.22M | 10.16M | 1.73M | 18.5M | 13.46M | 7.81M |
| FCF Growth % | -0.19% | 4.65% | 7.91% | 31% | -4.47% | -17.18% | 11.71% | -3.42% | 5.17% | 288.06% | -191.79% | 24.52% | -35.4% | 101.95% | 169.44% | -185.97% | -40.88% | 118.04% | 10.21% | -33.61% | 2.16% | -13.34% | -8.09% | 9.64% | 18.06% | 118.69% | 488.42% | -90.66% | 37.42% | 72.39% | -15.85% |
| FCF / Revenue % | 32.43% | 49.49% | 47.38% | 45.49% | 36.62% | 41.26% | 53.77% | 48.66% | 51.01% | 51.09% | -29.3% | 33.48% | 28.76% | 49.04% | 24.43% | -64.36% | 76.46% | 117.02% | 58.69% | 55.58% | 73.81% | 70.3% | 85.25% | 109.34% | 96.57% | 84.46% | 39% | 7.24% | 79.61% | 58.27% | 35.62% |
Quick answers to the most common questions about buying UHT stock.
Universal Health Realty Income Trust (UHT) generated $49.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Universal Health Realty Income Trust (UHT) generated $49.1M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Universal Health Realty Income Trust (UHT) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Universal Health Realty Income Trust (UHT) returned $41.0M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Unsustainable Dividend Payout
Metrics are mathematically derived from official filings.
Dividend Coverage Erodes as AFFO Data Vanishes
UHT's dividend payout ratio relative to AFFO has deteriorated to 0.81 in 2026Q2, but the complete absence of reported AFFO figures for the last ten quarters makes a definitive assessment of distributable cash flow sustainability impossible.
The provided data shows a Div/AFFO ratio, but the AFFO line itself is consistently blank, which is a critical data gap for a REIT analysis. The implied payout ratio has trended from 0.83 to 0.81, suggesting the dividend is consuming an increasing share of an unknown distributable cash flow figure. This warrants immediate investigation into the company's supplemental reporting to determine if AFFO is being reported under a different label or if the metric is intentionally omitted.
FFO Conversion Quality Remains Strong
UHT's FFO consistently exceeds GAAP operating cash flow, with an FFO/OCF ratio typically above 1.0, indicating that non-cash adjustments like straight-line rent are a net positive contributor to its core earnings metric.
For example, in 2026Q2, FFO of $12.9M exceeded OCF of $12.5M. This pattern, consistent across all quarters, suggests that the company's non-cash revenue recognition (likely straight-line rent) adds more to FFO than non-cash expenses like stock-based compensation deduct from it. This is a positive indicator of earnings quality, as it means the reported FFO is not being artificially inflated by cash flow timing differences.
Massive Depreciation Chasm Distorts Net Income
As reported in financial statements, UHT's GAAP net income of $5.9M in 2026Q2 is less than half of the $12.9M FFO, highlighting the massive depreciation charge that makes net income an unreliable metric for assessing this REIT's operational performance.
The FFO/NI ratio has fluctuated between 2.12 and 3.14 over the past ten quarters, demonstrating that depreciation is consistently the dominant factor suppressing GAAP earnings. This extreme distortion is typical for asset-heavy REITs but underscores why investors must focus on FFO and AFFO. The volatility in this ratio, particularly the spike to 3.14 in 2025Q4, may indicate non-recurring items or shifts in the depreciation schedule that merit further scrutiny.
Working Capital Swings Mask Underlying Collections
The significant quarterly volatility in operating cash flow relative to FFO, such as the $13.7M OCF versus $11.5M FFO in 2025Q2, suggests material swings in working capital components like tenant receivables and prepaid expenses that are not visible in the provided data.
The divergence between OCF and FFO is not constant, implying that cash collections from tenants or payments to operators are not perfectly aligned with the accrual-based revenue and expense recognition. For a healthcare facility REIT, this could signal variability in rent collection timing or the timing of operator reimbursements. Investors should monitor the cash flow statement for trends in 'change in operating assets and liabilities' to assess the quality and predictability of cash receipts.
Zero Reported Capex Raises Accounting Questions
UHT has reported $0 in capital expenditures for ten consecutive quarters, a figure that appears inconsistent with the maintenance needs of a portfolio of healthcare facilities and suggests these costs may be capitalized elsewhere or borne by operators.
This persistent zero is highly unusual for a REIT owning physical properties and likely indicates that maintenance capital expenditures are either fully reimbursed by tenants/operators, capitalized as part of acquisitions, or classified under a different line item. This accounting treatment artificially inflates free cash flow metrics like FCF and potentially AFFO, making it difficult to assess the true capital intensity of the business and the cash available for distribution without further disclosure.
What Could Invalidate the Base Case
The most significant analytical challenge is the historical 94% NOI margin, which appears unusually high and stable for a healthcare facility REIT, suggesting potential non-standard accounting or reimbursement structures that may not reflect true economic cash flow.
The prior income statement analysis flagged a severe NOI margin collapse to 8.7% in 2026Q2, a stark deviation from the historical 94% average. This volatility, combined with the complete absence of AFFO data and the persistent $0 CapEx, creates a high degree of uncertainty around the sustainability of the reported cash flows and the dividend. Investors should be wary that the historical cash flow profile may have been supported by accounting treatments or operator structures that are now changing, potentially invalidating the base case of stable, predictable distributions.